Smoking Cessation Resource Center Helping professionals help their patients quit smoking Home Our Products Literature Resources GSK Commitment Contact Us
Clinical Studies

Randomized controlled trial of a web-based computer-tailored smoking cessation program as a supplement to nicotine patch therapy

Victor J. Strecher, Saul Shiffman & Robert West
November 22, 2004

Aim
To assess the efficacy of World Wide Web-based tailored behavioral smoking cessation materials among nicotine patch users.

Design
Two-group randomized controlled trial.

Setting
World Wide Web in England and Republic of Ireland.

Participants
A total of 3971 subjects who purchased a particular brand of nicotine patch and logged-on to use a free web-based behavioral support program.

Intervention
Web-based tailored behavioral smoking cessation materials or web-based non-tailored materials.

Measurements
Twenty-eight-day continuous abstinence rates were assessed by internet-based survey at 6-week follow-up and 10-week continuous rates at 12-week follow-up.

Findings
Using three approaches to the analyses of 6- and 12-week outcomes, participants in the tailored condition reported clinically and statistically significantly higher continuous abstinence rates than participants in the nontailored condition. In our primary analyses using as a denominator all subjects who logged-on to the treatment site at least once, continuous abstinence rates at 6 weeks were 29.0% in the tailored condition versus 23.9% in the nontailored condition (OR=1.30; P=0.0006); at 12 weeks continuous abstinence rates were 22.8% versus 18.1%, respectively (OR=1.34; P=0.0006). Moreover, satisfaction with the program was significantly higher in the tailored than in the non-tailored condition.

Conclusions
The results of this study demonstrate a benefit of the web-based tailored behavioral support materials used in conjunction with nicotine replacement therapy. A web-based program that collects relevant information from users and tailors the intervention to their specific needs had significant advantages over a web-based non-tailored cessation program.

Contact us for more information on this study.


<< Back





 Clinical Studies Smoking Cessation Patient Materials Newsletter for Healthcare Professionals
GlaxoSmithKline Consumer Healthcare Commit NicoDerm CQ Nicorette


This site is intended for U.S. healthcare professionals only · Privacy Statement · Copyright © GlaxoSmithKline.